Innovation Pharmaceuticals Inc (IPIX)

[sundownsam]

This is all future expectation, which is a plus...

Innovation Pharmaceuticals
Treatment: Brilacidin

Type: Defensin mimetic in Phase II development in oral muscositis in Head and Neck Cancer patients

Status: Innovation said February 24 that it submitted a Material Transfer Agreement with an unidentified “leading U.S.-based virology laboratory” to study Brilacidin as a potential novel treatment for SARS-CoV-2. If lab tests prove successful, Innovation said, it will expedite research and clinical development of Brilacidin “via pharmaceutical partnerships, academic collaborations and government grants.” Innovation has also submitted a preliminary summary of Brilacidin’s potential for treating coronavirus to the Biomedical Advanced Research and Development Authority (BARDA).